Skip to content
Open access

Dual‐line Genome‐scale CRISPR Screening Enables Robust Target Gene Discovery

Aug 2026 · Advancement of science · 0 citations · 68 references
Medicine

TL;DR

It is shown that dual‐line screening can filter cell line‐specific artifacts and improve functional genomic screening for reliable genetic target discovery in insects and under cold stress, this framework identified candidate regulators of cold tolerance.

Abstract

ABSTRACT Pooled CRISPR screening enables genome‐scale functional gene discovery by linking genetic perturbations to cellular phenotypes. However, its application in insects remains limited, as systematic differences often obscure the universal functional signals and compromise the reliable identification of genetic regulators. We found that Cas9 genomic integration was associated with distinct transcriptional states, editing activity, and screening outcomes. To address this limitation, we developed a dual‐line CRISPR screening framework that prioritizes genes with concordant effects across independently derived Cas9‐expressing insect cell lines. In Bactrocera dorsalis, dual‐line consensus screening increased in vivo validation of candidate genes from 60% in single‐line screens to 90%. Under cold stress, this framework identified candidate regulators of cold tolerance, including a previously uncharacterized gene whose perturbation altered embryonic survival at low temperature. These results show that dual‐line screening can filter cell line‐specific artifacts and improve functional genomic screening for reliable genetic target discovery in insects.

Read PDF

Similar papers

Review Open access Sep 2026

High‐Content CRISPR Screening: Methods and Applications

This review synthesizes the methodological evolution of CRISPR screening, emphasizing advances in perturbation strategies, delivery systems, and multimodal readouts to demonstrate refined gene network annotations.

Yi-Ke Zhang, Yi-Meng Zhang, Xu-Dong Tang et al. · 0 citations
Open access Aug 2026

Perturb-ME: Scalable mechanism discovery from phenotype-enriched genome-wide screens

Perturb-ME, along with agentic interpretation, provide a scalable framework for comprehensive functional discovery from phenotype-enriched genetic screens and combines genome-scale CRISPR screening, phenotype-based enrichment and multimodal single-cell profiling.

Han-Chen Wang, Jiacheng Gu, Chris J. Frangieh et al. · 0 citations
Open access Aug 2026

Optimized parameters for CRISPR-Cas9 interference library design.

This work compares the performance of multiple KRAB domain systems, develops an updated CRISPRi-specific on-target scoring scheme, and quantitatively characterize off-target effects associated with seed-sequence patterns.

Smriti Srikanth, Fengyi Zheng, Laura M Drepanos et al. · 0 citations

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

An ECCITE-seq framework is described to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons and allows for the assessment of the regulatory impact of candidate genes implicat...

Jing-Long Zhang, K. Brennand, Bin Zhang et al. · 0 citations
#gene editing Open access Sep 2026

Combinatorial CRISPR/Cas12a excises targeted loci in the mammalian genome at very low efficiency

Findings indicate that the Cas12a system does not yield locus excision at the efficiency required for sensitive negative selection assays, and showed no meaningful correlation between gRNA efficiency, orientation, GC content, or cut site geometry and the success of locus excision.

N. Anvar, Zsofia M. Szegletes, R. Steger et al. · 0 citations
Open access Aug 2026

Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes

It is shown that off-target editing and translocations vary widely between individual cells and organs, motivating the development of more sensitive and organ-specific safety assays for CRISPR therapies.

Alexandra Madsen, Niklas Selfjord, M. Martinez-Lage et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.